Safe and effective use of lithium

Australian Prescriber

Volumn 36, Issue 1, 2013, Pages 18-21

  Malhi, Gin S ^a,b   Tanious, Michelle ^a,b   Bargh, Danielle ^a,b   Das, Pritha ^a,b   Berk, Michael ^c,d,e,f  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e BARWON HEALTH   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Bipolar disorder; Mood stabiliser; Tolerability

Indexed keywords

LITHIUM; VALPROIC ACID;

ARTICLE; BIPOLAR DISORDER; DEPRESSION; DIARRHEA; DOSE KIDNEY FUNCTION RELATION; DRUG ACCUMULATION; DRUG EFFICACY; DRUG EXCRETION; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOTHYROIDISM; LITHIUM BLOOD LEVEL; MAINTENANCE THERAPY; MAJOR DEPRESSION; MANIA; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; PARATHYROID DISEASE; PATIENT ATTITUDE; PATIENT COMPLIANCE; POLYURIA; RAPID CYCLING BIPOLAR DISORDER; SIDE EFFECT; SUICIDAL IDEATION; SUSTAINED RELEASE FORMULATION; TERATOGENICITY; THIRST; THYROID DISEASE; TREMOR; VOMITING; WEIGHT GAIN;

EID: 84873326217     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2013.008     Document Type: Article

References (14)

1. Malhi GS, Adams D, Berk M. Is lithium in a class of its own? A brief profile of its clinical use. Aust N Z J Psychiatry 2009;43:1093-104.
2. Young AH, Hammond JM. Lithium in mood disorders: increasing evidence base, declining use? Br J Psychiatry 2007;191:474-6.
3. Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 2004;161:217-22.
4. Van Lieshout RJ, MacQueen GM. Efficacy and acceptability of mood stabilisers in the treatment of acute bipolar depression: systematic review. Br J Psychiatry 2010:196;266-73.
5. Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 2010;375:385-95.
6. Malhi GS, Adams D, Lampe L, Paton M, O'Connor N, Newton LA, et al. Clinical practice recommendations for bipolar disorder. Acta Psychiatr Scand Suppl 2009:27-46.
7. Fountoulakis KN. An update of evidence-based treatment of bipolar depression: where do we stand? Curr Opin Psychiatry 2010;23:19-24.
8. Yatham L, Kennedy SH, Schaffer A, Parikh SV, Beaulieu S, O'Donovan C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 2009;11:225-55.
9. Bendz H, Aurell M. Drug-induced diabetes insipidus: incidence, prevention and management. Drug Saf 1999;21:449-56.
10. McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet 2012;379:721-8.
11. Ng F, Mammen OK, Wilting I, Sachs GS, Ferrier IN, Cassidy F, et al. The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord 2009;11:559-95.
12. Berk L, Hallam KT, Colom F, Vieta E, Hasty M, Macneil C, et al. Enhancing medication adherence in patients with bipolar disorder. Hum Psychopharmacol 2010;25:1-16.
13. Berk L, Jorm AF, Kelly CM, Dodd S, Berk M. Development of guidelines for caregivers of people with bipolar disorder: a Delphi expert consensus study. Bipolar Disord 2011;13:556-70.
14. Malhi GS, Tanious M, Gershon S. The lithiumeter: a measured approach. Bipolar Disord 2011;13:219-26.